Late Stage Clinical Product Development Strategy

Source: Halloran Consulting Group


Our deep expertise in translational and clinical sciences combined with strong operational background allows us to evaluate each client's assets as unique commercial opportunities. We guide our clients through critical strategic decisions at product transition points, and help them manage partnerships or other collaborative alternatives.

A well-articulated plan is important to align development strategy with company operations. Halloran works with companies to ensure strategy cohesiveness from initial candidate selection through late stage clinical design.

Candidate Selection
In candidate selection, our consultant's extensive scientific and operational experience is paired with a database matching indications, development paths and current treatment regimens. Our seasoned team has helped many clients with broad technologies and multiple applications to select the right candidates and prioritize their portfolios.

Our clients include early stage companies requiring planning support to reach a funding milestone, and late stage companies with marketed products needing to refocus their strategy.